Back

Genetic abrogation of osteopontin mitigates cardiac dysfunction and arrhythmias via preventing myocardial inflammation in arrhythmogenic cardiomyopathy

12 June 2026 (10:31 - 10:34)
Organised by: Logo
Seminar Presentation Part of: Module B: Mentoring & how-to sessions - Poster rapid fire session 3 Cardiomyopathies Open Access Basic Science Course 2026 ESC Fund

About the speaker

Photo
Doctor Andrea Villatore

IRCCS San Raffaele Scientific Institute, Milan (Italy)

9 More presentations in this session

Presentation thumbnail
Exploring the ability of cell competition-mediated cardiac regeneration
Miss G. Conceicao (Madrid, ES)
Presentation thumbnail
The role of valve endothelial cells in aortic valve calcification
Miss D. Evensen (Oslo, NO)
Presentation thumbnail
Cardiometabolic combination therapies target inflammation-driven atrial remodeling in atrial fibrillation
Doctor W. Fakih (Strasbourg, FR)
Presentation thumbnail
CCL2 aggravates thrombosis by upregulating platelet P2Y12 receptor via CCR2: mechanisms and therapeutic implications
Ms C. Gu (Beijing, CN)
Presentation thumbnail
Divergent hemodynamic Responses to Trimethylamine (TMA) in Hypertensive Rats: Uncovering a Novel Role for the TAAR5 Receptor
Doctor K. Jaworska (Warsaw, PL)

Access the full session

Session thumbnail
Module B: Mentoring & how-to sessions - Poster rapid fire session 3

The Event

Event poster

Basic Science Course 2026

12 June 2026 10:31 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources